Healthcare Delivery

Why developing new antibiotics is a matter of life and death

Antibiotic-resistant superbugs kill 700,000 people worldwide each year, but what's stopping the development of new treatments?

Kasim Kutay

Chief Executive Officer, Novo Holdings

Share:

Our Impact
The Big Picture
Explore and monitor how Healthcare Delivery is affecting economies, industries and global issues
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale

Stay up to date:

Healthcare Delivery

Have you read?

Deaths from drug-resistant infections by 2050

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:

Healthcare DeliveryGlobal HealthHealth and HealthcareDavos 2020

Share:

Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

The importance of securing healthcare data
About Us
Events
Media
Partners & Members
Language Editions

Privacy Policy & Terms of Service

© 2022 World Economic Forum